News Quantified

SXTC – china sxt pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

China SXT Pharmaceuticals files for $120M mixed securities shelf [Seeking Alpha]

China SXT Pharmaceuticals receives noncompliance notification from Nasdaq [Seeking Alpha]

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Form EFFECT China SXT Pharmaceutical

Form SC 13G/A China SXT Pharmaceutical Filed by: Streeterville Capital LLC

Form F-3 China SXT Pharmaceutical

Form 6-K China SXT Pharmaceutical For: Oct 15

Top News Gainers

8/12 China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate 20.3%

4/22 Form 6-K China SXT Pharmaceutical For: Sep 30 17.9%

1/24 China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production 13.5%

1/31 Form 6-K China SXT Pharmaceutical For: Jan 31 7.0%

1/16 China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory 5.6%

9/11 China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques 4.0%

3/16 China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government 2.5%

5/3 Form 6-K China SXT Pharmaceutical For: May 03 2.3%

7/31 Form NT 20-F China SXT Pharmaceutical For: Mar 31 1.7%

8/19 China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019 1.5%

Top News Decliners

1/28 China SXT Pharmaceuticals Inc (NASDAQ: SXTC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -20.0%

3/31 Form 6-K China SXT Pharmaceutical For: Mar 31 -19.5%

2/4 China SXT Pharmaceuticals Inc (NASDAQ: SXTC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -17.3%

3/12 China SXT Pharmaceuticals Inc (NASDAQ: SXTC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -14.6%

6/21 Form F-1/A China SXT Pharmaceutical -13.0%

11/5 Form 424B8 China SXT Pharmaceutical -13.0%

12/16 Form 6-K China SXT Pharmaceutical For: Dec 16 -10.9%

3/10 Form 6-K China SXT Pharmaceutical For: Mar 10 -10.6%

2/28 China SXT Pharmaceuticals Inc (NASDAQ: SXTC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -10.2%

3/4 Form 6-K China SXT Pharmaceutical For: Mar 03 -9.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day